Gå till innehåll

Regionernas samverkansmodell för läkemedel och medicintekniska produkter.


Based on ethical considerations and the health economic evaluation of the medicine or new indication, the New Therapies Council makes a decision on a recommendation to the county councils on use. The New Therapies Council estimates willingness to pay by weighing the severity of the disease, the clinical effect of the treatment, the rareness of the disease and the uncertainty in the clinical data against the estimated cost per QALY.


The New Therapies Council recommendations are published on the website for national managed introduction of new medicines, and are communicated directly via email the county councils.

Senast ändrad